comparemela.com

Latest Breaking News On - Oregon medical research center - Page 1 : comparemela.com

Early Improvement in Prurigo Nodularis With IL-31 Antagonist Maintained at 1 Year

Itch, sleep disturbance, lesion healing, quality of life improved substantially in most patients

Portland
Oregon
United-states
American
Shawng-kwatra
Andrew-blauvelt
Charles-bankhead
Oregon-medical-research-center
Johns-hopkins-itch-center
American-academy-of-dermatology
American-academy
Investigator-global-assessment

Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA

Blauvelt discusses the future research of higher-dose risankizumab for patients with psoriasis and why it may be "disruptive in the treatment space."

Oregon
United-states
San-diego
California
American
Andrew-blauvelt
American-academy-of-dermatology
Oregon-medical-research-center
American-academy
Aad
Psoriasis
Knockout

Rizankizumab and the KNOCKOUT Study, with Andrew Blauvelt, MD, MBA

Blauvelt discusses the impetus for his phase 2 trial looking at the ability to mitigate pivotal psoriasis memory T cells with risankizumab.

San-diego
California
United-states
Oregon
American
Andrew-blauvelt
American-academy-of-dermatology
Oregon-medical-research-center
American-academy
Psoriasis-area-severity-index
Risankizumab
Skyrizi

Are High Doses of Skyrizi a Cure for Plaque Psoriasis?

A "hit-it-hard, hit-it-early" strategy might eventually cure plaque psoriasis, says the researcher conducting a small study of high-dose Skyrizi that has produced promising results. Even so, the disease is not vanquished and "trickles back."

Oregon
United-states
Portland
San-diego
California
American
Andrew-blauvelt
Oregon-medical-research-center
American-academy-of-dermatology
American-academy
Psoriasis-area
Severity-scale

Home- and Office-Based Phototherapy for Psoriasis Compared

The multicenter LITE trial included 783 patients at 42 sites in the United States.

United-states
Philadelphia
Pennsylvania
Oregon
University-of-pennsylvania
Portland
American
Andrew-blauvelt
Joelm-gelfand
Oregon-medical-research-center
Psoriasis-foundation
Improvement-in-health-equity

vimarsana © 2020. All Rights Reserved.